Skip to Content

Join the 'Belviq' group to help and get support from people like you.

Belviq News

Weight-Loss Drug Belviq (lorcaserin) Is First to Show No Harm to Heart

Posted 27 Aug 2018 by Drugs.com

MONDAY, Aug. 27, 2018 – The weight-loss drug Belviq (lorcaserin) appears to help people shed pounds without adversely affecting the heart in those already at higher heart risk, new research shows. That's a first – and a major hurdle overcome – for medicines specifically aimed at weight loss, experts say. In the 1990s, the "fen-phen" combo of weight-loss meds (fenfluramine and phentermine) made...

Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of Belviq XR (lorcaserin HCl) Extended-Release Tablets

Posted 20 Jul 2016 by Drugs.com

WOODCLIFF LAKE, N.J. and SAN DIEGO, July 19, 2016 /PRNewswire/ – Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Belviq XR (lorcaserin HCl) CIV extended-release 20 mg tablets. The new formulation of lorcaserin will offer patients a once-a-day dosing option that may help them...

Ask a Question

Further Information

Related Condition Support Groups

Weight Loss, Obesity

Belviq Patient Information at Drugs.com